{"id":"NCT01033825","sponsor":"Sumitomo Pharma America, Inc.","briefTitle":"Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis","officialTitle":"A 6-Week Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Safety and Efficacy Study of the Potential Inhibitory Effects on the Hypothalamic-Pituitary-Adrenal Axis of Ciclesonide HFA Nasal Aerosol and Ciclesonide Aqueous Nasal Spray in Subjects 12 Years and Older With Perennial Allergic Rhinitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-01","primaryCompletion":"2010-05","completion":"2010-05","firstPosted":"2009-12-17","resultsPosted":"2012-07-19","lastUpdate":"2012-07-19"},"enrollment":310,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Perennial Allergic Rhinitis"],"interventions":[{"type":"DRUG","name":"Ciclesonide HFA Nasal Aerosol 320 mcg","otherNames":[]},{"type":"DRUG","name":"Ciclesonide HFA Nasal Aerosol 160 mcg","otherNames":[]},{"type":"DRUG","name":"HFA Nasal Aerosol placebo","otherNames":[]},{"type":"DRUG","name":"Ciclesonide Aqueous Nasal Spray 200 mcg","otherNames":["Omnaris"]},{"type":"DRUG","name":"AQ Nasal Spray Placebo","otherNames":[]},{"type":"DRUG","name":"Placebo plus Dexamethasone HFA","otherNames":["Decadron"]},{"type":"DRUG","name":"Placebo AQ plus Dexamethasone 6 mg","otherNames":[]}],"arms":[{"label":"Ciclesonide HFA Nasal Aerosol 320 mcg","type":"EXPERIMENTAL"},{"label":"Ciclesonide HFA Nasal Aerosol 160 mcg","type":"EXPERIMENTAL"},{"label":"HFA Nasal Aerosol placebo","type":"PLACEBO_COMPARATOR"},{"label":"Ciclesonide Aqueous Nasal Spray 200 mcg","type":"EXPERIMENTAL"},{"label":"AQ Nasal Spray Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Placebo HFA plus Dexamethasone 6 mcg","type":"ACTIVE_COMPARATOR"},{"label":"Placebo AQ plus Dexamethasone 6 mg","type":"ACTIVE_COMPARATOR"}],"summary":"To demonstrate the effects of ciclesonide applied as a nasal aerosol and ciclesonide aqueous (AQ) nasal spray on hypothalamic-pituitary-adrenal axis.","primaryOutcome":{"measure":"Serum Cortisol Area Under the Concentration-time Curve (AUC)(0-24h) at Baseline","timeFrame":"Baseline","effectByArm":[{"arm":"Ciclesonide HFA Nasal Aerosol 320 Mcg","deltaMin":183.2,"sd":61.9},{"arm":"Ciclesonide HFA Nasal Aerosol 160 Mcg","deltaMin":171.7,"sd":40.1},{"arm":"HFA Nasal Aerosol Placebo","deltaMin":173.1,"sd":53.5},{"arm":"Ciclesonide Aqueous Nasal Spray 200 Mcg","deltaMin":172.8,"sd":42.5},{"arm":"Placebo Aqueous Nasal Spray","deltaMin":179,"sd":37.9}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":18},"locations":{"siteCount":6,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":48},"commonTop":["Epistaxis","Headache","Nasopharyngitis","Nausea","Nasal septum disorder"]}}